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INTRODUCTION
The presence of antibiotic-resistant bacteria is a big problem, threatening human health. Due to the immoderate use of antibiotics, resistant strains of bacteria are being created increasingly. [1] One of these bacteria is Pseudomonas aeruginosa which exists in oral cavity ulcers, in patients with absolute neutropenia or neutropenia caused by chemotherapyradiotherapy, neutropenia associated with leukemia and lymphoma, neutropenia in HIV-positive individuals, non-Hodgkin lymphoma, in infected sores in mouth burns, as well as in infections often associated with neutropenia and caused by unusual oral pathogens, [1, 2] and so is challenging for oral diseases specialists.
Since some strains have been created which have acquired resistance to last-line antibiotic treatment, researchers are prompted to look for alternative treatments. One of the alternative treatments is phage therapy. [3, 4] Phage therapy is in the fact that the use of parasite viruses as anti-bacterial agents, which are taken into account again due to their harmlessness and capability for defying bacterial resistance. [5] Phages are very effective for local infections; because, by proliferation through bacteria, they can penetrate into deep infected areas where antibiotics cannot access. [6] Usefulness of phage therapy for P. aeruginosa biofilms in root canal models has recently been studied. Using phage has satisfactorily reduced, the 24-h and 96-h biomasses of P. aeruginosa biofilms grown on microplates but has failed to reduce the 24-h and 96-h P. aeruginosa grown in extracted teeth models. [7] Watanabe et al. conducted an investigation on phage therapy for intestinal infections in mice caused by P. aeruginosa. Mice treated with phage had less living Pseudomonas cells in their liver and spleen blood compared to the control group. [8] Because of the increase of bacterial resistance and lack of therapeutic response even to last-line antibiotics, and also numerous side effects of powerful antibiotics, as well as inability of antibiotics to access deep infected areas such as mouth ulcers; we were prompted to identify and isolate P. aeruginosa specific phage from enriched sludge and investigate its therapeutic effects on standard strains and strains with resistance genes.
MATERIALS AND METHODS
This study was approved by vice-chancellor of Tabriz University of Medical Sciences and was granted by Drug Applied Research Center. P. aeruginosa strains used in the present project including strains with different resistance genes, P. aeruginosa ATCC 27853, P. aeruginosa SPM-1, P. aeruginosa BIC, P. aeruginosa VIM-2, P. aeruginosa AIM, P. aeruginosa multi-drug resistant clinical isolate 1 and isolate 2 were provided by Iranian Research Organization for science and technology and Persian type culture collection. Two clinical strains of P. aeruginosa isolated from mouth were identified by biochemical methods and antibiogram were done according to previously described methods. [2] The sludge sample used in this research was taken from wastewater of the faculty of dentistry of Tabriz University of Medical Sciences and also from running water and wastewater of an industrial estate.
Phage enrichment technique
Samples were first centrifuged at 4000 rpm for 10 min, and then, 50 mL of the supernatant of the centrifuged samples was removed, and enrichment was done by the standard protocol as previously described. [9] Double-layer agar
To investigate the creation of plaque, the double-layer agar method was used. In this method, 0.2 mL of the filtered liquid was added to a test tube, and then 0.1 mL of the 24-h culture of the intended strain plus 2.5 mL of nutrient agar (0.7% agar) melted at 45°C were added. Culturing was performed at the solidified environment of nutrient agar (1.5%). Incubation was performed at 37°C for 48 h and then plaques created in the plate were removed by a sterile loop. Plaques were poured into a sterile Erlenmeyer flask, then 50 mL of nutrient broth 0.5 cc of the bacterial suspension with a 24-h growth was added and placed in a shaking incubator for 24 h. After 24 h, the solution containing phage and bacteria was the first centrifuged at 14000 rpm for 10 min and the supernatant was filtered by a 0.45 filter. The filtered sample was examined once again using spot method to observe the double-layer agar plaque. This procedure was repeated several times to produce a large amount of pure phage. [9] Spot test method
In the Spot test method, 0.1 mL of the bacterium suspension with 24-h growth mixed with 2.5 mL of 0.7% nutrient agar were used. This mixture was added to plates containing nutrient with 1.5% agar. Doublelayer plates were created and when the upper layer agar was gelled, 5 µL of the phage solution was added as spot into the plate of each bacterium. The plates were incubated at 37°C for 48 h. The observed transparent halo indicates bacterium's sensitivity to phage. [10] Identification of phage To observe the phage structure, uracil negative staining protocol [11] was used. Samples were solved in water on the slide, and a copper grade was solved on 20 µL of phage and placed in water for 4 min. Then, the samples were examined using an electron microscope. [11, 12] 
RESULTS
In the present examination, two types of phages were isolated and identified from enriched sludge through microbial pentavalent compound. In the next step, uracil negative staining was conducted and isolated phages were observed under an electron microscope [ Figures 1]. The two isolated bacteriophages belong to Plasmaviridae and Inoviridae families. Plasmaviridae family includes a circular double-stranded DNA genome with coating and lipid, without capsid. Inoviridae family includes a circular single-stranded DNA genome without coating. Figure 2 shows the effect of extracted phages on P. aeruginosa SPM harboring strain and the growth inhibition of all isolates are presented in Table 1 .
DISCUSSION
Spread of treatment-resistant bacteria in recent years has prompted researchers to think of new treatment methods including phage therapy. Bacteriophages are among important antibacterial factors which specifically attack host bacteria and destroy them. Lytic phages are proliferated within bacteria and result in the production of a large number of phages and, eventually, in their death. [13] In this study, two phages of Inoviridae and Plasmaviridae families were extracted. They had bactericidal effects. According to our knowledge, as for Pseudomonas, these families of phages have been introduced for the first time.
Inoviridae is bacteriophages with circular singlestranded DNA and capsid. DNA strands have spiral symmetry, and these viruses are 760 and 1950 nm long and 8.6 nm wide). They have five or more proteins in their capsids, being gp8. Their genome is integrated and circular with the filament. [14] These viruses are reported as natural Pseudomonas bacteriophages. [15, 16] Plasmaviridae is bacteriophages with polymorph circular double-stranded DNA, envelope, cover, and lipid, without capsid, and seem circular. Further, they are dense, integrated, and non-segmental and are consisted of a single circular molecule. Their genome has a relatively high content of G-C. [14, 15] This family of bacteriophage has not been reported for P. aeruginosa till now. The extracted phage has been enriched once; further enrichment of this phage would certainly increase its anti-microbial effect. Results show their good effect on the strains.
In this study, in the strains of P. aeruginosa PAO1, P. aeruginosa ATCC 27853, and P. aeruginosa SPM-1, growth inhibition halo was seen in three dilutions of 1, 1:10, and 1:20, and the diameter of the growth inhibition halo was reduced with the increase of dilution in all three strains. Further, in both examined clinical strains, growth inhibition was seen to be similar to that of the SPM-1 carrier strain.
Betts et al. (2013) showed that using phages causes complete elimination of treatment-resistant Pseudomonas, [17] which is consistent with this study.
Phages can infect a host when they are able to enter it after reacting with bacterial receptors. [14] Most discovered phages have a high specificity for receptors present in their host. They have shown no reaction with receptors of different structures. Specificity of phages forms the basis of typing phages used in identification of bacterial strains. [14, 15] In this study, using phages against the Pseudomonas was performed in vitro. There are many differences between in vivo and in vitro environments. In vivo is a more complicated environment where there are many obstacles a phage should pass to reach the target bacteria. Weld et al. (2004) found that bacteriophages have a different and complicated growth cycle in vivo. [18] One problem is that spleen becomes activated and deactivates phages before they find the opportunity to reach their bacterial targets.
These phages can be used as mouthwashes to solve oral problems; therefore, there will be no problem of spleen removal, and development of their use as mouthwash, led them to be used in oral infections than in systemic infections.
Several studies have introduced the use of bacteriophages as a secondary treatment method so that they have been used for the treatment of diseases such as oral ulcers, typhoid fever, cholera, diarrhea, and other infectious diseases. [19] [20] [21] In 2006, March and Clark treated legs with venous ulcers infected by antibiotic-resistant Pseudomonas in 5 months using bacteriophages, which showed an instance of the effectiveness of phages, and also showed that using phages has minimum side effects. [22] Phages are smart drugs whose lives depend on their bacterial targets; furthermore, they have special bacterial hosts and, as a result, do not hurt natural microflora of body. Contamination of vaccines with phages in 1970, which resulted in no problem or disease, indicates the safety of clinical use of phages. Integration of phages to treat oral ulcers will certainly improve treatment outcomes.
Based on results of this study and other similar studies, phages can help inhibiting oral P. aeruginosa infections. An animal model and clinical study are suggested to examine the effectiveness of phages for treating the oral ulcers because the use and development of these phages as mouthwash can significantly help control oral ulcers without using antibiotics. 
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